Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Jun;50(4):382-383.
doi: 10.1016/j.medmal.2020.04.002. Epub 2020 Apr 4.

Interleukin-6 as a potential biomarker of COVID-19 progression

Zulvikar Syambani Ulhaq  1 , Gita Vita Soraya  2
Affiliations
Meta-Analysis

Interleukin-6 as a potential biomarker of COVID-19 progression

Zulvikar Syambani Ulhaq et al. Med Mal Infect. 2020 Jun.
No abstract available

Keywords: Biomarker; COVID-19; IL-6.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Forest plot for pooled standardized mean difference (SMD) and 95% confidence interval (95% CI) of circulating IL-6 levels in COVID-19-infected patients with severe and non-severe condition.
Fig. 2
Fig. 2
Sensitivity analysis of changes in IL-6 levels of COVID-19-infected patients.
See this image and copyright information in PMC

References

    1. Chen X., Zhao B., Qu Y., Chen Y., Xiong J., Feng J., et al. Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely associated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients. bioRxiv. 2020 doi: 10.1101/2020.02.29.20029520. - DOI - PMC - PubMed
    1. Wang H., Luo S., Shen Y., Li M., Zhang Z., Dong Y., et al. Multiple enzyme release, inflammation storm and hypercoagulability are prominent indicators for disease progression in COVID-19: a multi-centered, correlation study with CT imaging score. SSRN. 2020 doi: 10.2139/ssrn.3544837. - DOI
    1. Yang P., Ding Y., Xu Z., Pu R., Li P., Yan J., et al. Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, China. bioRxiv. 2020 doi: 10.1101/2020.02.28.20028068. - DOI
    1. Liu J., Ouyang L., Guo P., Wu H.S., Fu P., Chen Y.L., et al. Epidemiological, clinical characteristics and outcome of medical staff infected with COVID-19 in Wuhan, China: A retrospective case series analysis. bioRxiv. 2020 doi: 10.1101/2020.03.09.20033118. - DOI
    1. Zhou F., Yu T., Du R., Fan 4, Liu Y., Liu Z., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 doi: 10.1016/S0140-6736(20)30566-3. [pii: S0140-6736(20)30566-3] - DOI - PMC - PubMed

LinkOut - more resources